Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Genpax logo — Connecting Pathogen Genomics

Genpax

Connecting Pathogen Genomics

Founded 2021 United Kingdom London, United Kingdom 38 employees Seed Total: $2.70M Analytics, Biotechnology

General Information

Company Name Genpax
Founded Year 2021
Location United Kingdom London, United Kingdom +2
Founders / Decision Makers
Nigel Saunders MBChB PhD Saunders — Chief Scientific Officer GENPAX
Employees 38
Industries Analytics, Biotechnology
Funding Stage Seed
Social

Get notified when Genpax moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Genpax

Genpax is a pioneering startup in the United Kingdom that is disrupting the field of infectious disease investigation with its groundbreaking surveillance tool, IDEM. Utilizing whole genome sequencing analysis, IDEM employs precision genomics to reveal the true relationship between bacterial isolates, providing a comprehensive solution to strain identification and outbreak management. This has the potential to provide unrivaled accuracy and resolution to transmission events, while also equipping healthcare professionals with markers of clinical significance. The startup was founded in 2021 and operates in the analytics and biotechnology industries. Their most recent milestone is the successful Fr.2.70MSeed Round investment on01 March 2022.

Taxonomy: genome sequencing, infectious disease, precision genomics, bacterial isolates, strain identification, outbreak management, transmission events, clinical significance, biotech, medtech, healthtech

Services & Products

Whole Genome Sequencing Analysis Platform

Target Customers

Healthcare Systems Governments Industry

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Fr.2.70M - 01 Mar 2022

Genpax Alternatives & Competitors

Genpax vs
IDEM
IDEM

Short term rental of computer equipment and infrastructure

724 employees
Hardware, IT
Genpax vs
Idem Hospitality
Idem Hospitality

Event-housing solutions for event planners & hotels to improve productivity & revenue while reducing...

Angel
2 employees
Hospitality
Compare Genpax vs Idem Hospitality
Genpax vs
Idem Translations, Inc.
Idem Translations, Inc. United States

Taking the Risk Out of Translation

42 employees
Also compare with: Genpax vs Mytos Mytos Genpax vs C & I Electronics Co., Inc. C & I Electronics Co., Inc.

FAQ About Genpax

Connecting Pathogen Genomics
Genpax was founded in 2021.
Genpax is headquartered in London, United Kingdom.
Genpax operates in the following industries: Analytics, Biotechnology.
Genpax has approximately 38 employees.
Genpax has completed 1 funding round, raising a total of $2.70M. The latest funding stage is Seed.
Genpax offers: Whole Genome Sequencing Analysis Platform.
Top alternatives and competitors to Genpax include IDEM, Idem Hospitality, Idem Translations, Inc., IDEM Safety Switches, Mytos. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genpax and IDEM are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Genpax and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy